Sano Genetics reposted this
Senior executive with deep experience in strategic partnerships, marketing and business development.
Frontotemporal dementia (#FTD) may not be as widely recognized as #Alzheimers, but its impact is just as profound. I was so humbled to have the opportunity to speak with Dr. @Brad Dickerson of Massachusetts General Hospital during BrightFocus Foundation’s recent Zoom In on Dementia & Alzheimer’s episode. The conversation was insightful, inspiring, and packed with key takeaways for anyone affected by neurodegenerative diseases. Dr. Dickerson’s depth of knowledge and compassionate approach made this an especially resonant conversation – sharing the latest FTD research findings, clinical trial options, and practical advice anyone can benefit from. Whether you’re a caregiver, healthcare professional, or just looking to learn more about #brainhealth, I encourage you to tune in. https://bit.ly/3zHuAJP The Association for Frontotemporal Degeneration (AFTD), Sano Genetics, Biogen, Eli Lilly and Company, Genentech